Updated September 2026Names the pharmacy, not sellingEdgeRx review
A seller that names who compounds its medication also says its protocols are not currently available to buy.
The verdict
EdgeRx publishes $199 a month for semaglutide and $225 for tirzepatide, re-read in September 2026, names Strive Pharmacy as the 503A that compounds both, and states on each protocol page that the protocol is not currently available for purchase.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 46
- From
- $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Named
- Availability
- 46 states
EdgeRx sells both molecules by injection, each formulated with glycine and B12, with coverage recorded across 46 states and a named compounding pharmacy behind both lines.
Who writes the prescription, and what do they see?
The prescriber is not described, but the pharmacy is, and on a question about who stands behind the medicine that is the rarer half of the answer. A buyer can look up a 503A registration in a way they cannot look up an unnamed one.
Naming Strive Pharmacy is a real disclosure and it deserves saying plainly, because a compounded vial from an unnamed facility is a product whose chain of custody a reader has no way to check. The availability notice sits awkwardly beside it: the published rates describe something the pages say cannot currently be bought.
What happens when the dose goes up?
Nothing is published about what either figure does at a higher dose. The glycine and B12 formulation is described in more detail than the dose ladder is, which inverts the usual priority for a buyer about to spend four months escalating.
What the price includes
Both figures came down between readings, semaglutide from $229 to $199 and tirzepatide from $299 to $225. Six months at the new rates is $1,194 and $1,350. Those totals assume the protocols become purchasable, which the pages currently say they are not, so treat both as quoted rather than available.
What it claims, and what it cites
Both lines are compounded rather than manufactured and are prepared by Strive Pharmacy, a 503A facility the seller names. The FDA does not review a compounded preparation before it is dispensed, and a named pharmacy does not change that — it changes only whether a reader can find out who made it.
Where it holds up, and where it does not
- Strength: Names Strive Pharmacy as the compounder
- Strength: Coverage recorded across 46 states
- Strength: Both figures fell between readings
- Strength: The formulation is described in detail
- Limitation: Both protocols say not available to purchase
- Limitation: Nothing published about dose pricing
- Limitation: The availability notice is easy to miss
What the evidence says about this kind of treatment
The assessment above is about EdgeRx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants a named compounding pharmacy and will check availability first.
- Wrong for
- A reader who needs to order today.
How EdgeRx compares
| Seller | Who it suits | Go |
|---|---|---|
| Contour Health | Readers who would rather see an honest average than a flat rate that hides the ladder | See Contour Health → |
 DrBrainRx | Readers escalating to a high dose who want the rate pinned across it | See DrBrainRx → |
| Elevated Health | Readers who want to see every rung before choosing a term | See Elevated Health → |
More GLP-1 telehealth sellers reviews: NextMedsNoBsRxNovaNovoCare PharmacyNuBloomNucore Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Can I actually buy this?
- The protocol pages for both molecules state the protocol is not currently available for purchase, so the published rates describe something a reader should confirm is buyable before planning around it.
- Who compounds the medication?
- Strive Pharmacy, a 503A facility, which EdgeRx names on its own pages, and a named 503A is checkable against a public registration.
- What do the two lines cost?
- $199 a month for semaglutide and $225 for tirzepatide, re-read in September 2026, down from $229 and $299 a month earlier.
- Is EdgeRx legit?
- EdgeRx is a GLP-1 telehealth sellers service. Its stated availability: 46 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is EdgeRx expensive compared with other GLP-1 telehealth sellers?
- EdgeRx publishes a starting figure of $199/mo. Across the 112 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts EdgeRx above the median. The other 8 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.